Related Experiment Video
Updated: Jul 24, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Laboratory approaches to the diagnosis of hepatitis C virus infection
1Department of Laboratory Medicine, University of Washington Medical Center, Seattle, WA 98366, USA.
Insights
Hepatitis C virus (HCV) testing, including molecular and genotyping assays, is crucial for managing the global epidemic. Advanced lab diagnostics combined with new therapies promise better HCV treatment outcomes.
Area of Science:
- Hepatology
- Virology
- Clinical Diagnostics
Background:
- Hepatitis C virus (HCV) infection presents a significant global health challenge.
- Laboratory testing is essential for managing the HCV epidemic effectively.
Purpose of the Study:
- To highlight the critical role of laboratory diagnostics in the detection and management of HCV.
- To emphasize the advancements in molecular and genotyping assays for HCV patient care.
Main Methods:
- Serologic tests for HCV antibodies used in screening.
- Qualitative molecular tests for confirming positive screening results.
- Quantitative molecular tests and genotyping assays for prognostic information and treatment monitoring.
Main Results:
- Serologic tests are valuable for initial HCV screening.
- Molecular tests confirm diagnoses and provide prognostic data.
- Genotyping assays guide treatment decisions and predict therapy response.
Conclusions:
- Laboratory testing, particularly molecular and genotyping methods, is central to effective HCV management.
- Improvements in diagnostics coupled with novel antiviral drugs are expected to significantly enhance HCV disease treatment.
Abstract:
Hepatitis C virus (HCV) infection is a major and growing health problem worldwide. Laboratory testing plays an important role in the response to the HCV epidemic. Serologic tests for antibody to HCV are useful for screening purposes. The mainstays of laboratory testing for HCV, however, are the molecular approaches. Qualitative molecular tests are useful for confirmation of positive screening tests. Quantitative molecular tests provide prognostic information regarding the likelihood of response to therapy, and allow the monitoring of treatment efficacy. Similarly, genotyping assays predict response to therapy, and allow rational decisions regarding duration of treatment. The combination of continually improving laboratory testing, together with new drugs targeting distinct molecular determinants that are either essential or important in the viral replication cycle, is likely to lead to dramatic improvements in the management of HCV disease.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Viral Hepatitis I: Introduction